Green, matcha, and black tea: Effective weapons against Omicron subvariants, research reveals

CHICA­GO – More than 40,000 clin­i­cians, bio­phar­ma ex­ec­u­tives, in­vestors, drug sales­peo­ple and many oth­ers in­volved in can­cer re­search de­scend­ed up­on Mc­Cormick Place in Chica­go for

Bi­o­log­ics start­up Elek­trofi is rais­ing an ap­prox­i­mate­ly $112 mil­lion Se­ries C, CEO and co-founder Chase Coff­man con­firmed to End­points News. The Boston-based start­up works with

The revenue for Navitoclax dihydrochloride is expected to reach an annual total of $315 mn by 2034 in the US based off GlobalData’s Expiry Model.